|
|
 |
|
Viewing report
|
|
|
|
The CNS Market 2008 Report
NeuroInsights, May 2008
Drugs, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets
Now in its fourth year, The CNS Market 2008 Report is an expanded and updated 400 page report of brain and nervous system markets and treatments. It is the only publication to provide a unified market-based framework to help investors, companies and entrepreneurs easily quantify opportunities, determine risks and understand the dynamics of rapidly changing CNS markets.
The report tracks advances in more than 16 indications at 500 companies including Alzheimer’s, addiction, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, multiple sclerosis, obesity, pain, Parkinson’s, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, and stroke.
Report Highlights
The CNS Market 2008 Report provides a unified market-based framework to help executives, investors, and governments easily quantify opportunities, determine risks and understand the dynamics of this rapidly growing market.
-500 profiles of public and private neurotech companies including drugs, devices and diagnostics
-12 most active neurotech venture capital firms profiled with investments by market segment and U.S. neurotech venture capital trends (1999-Q1 2008)
-Neurotech IPOs (2004-Q1 2008), M&A (2004-Q1 2008), Partnering and Licensing deals (2005-Q1 2008) and public neurotech stock performance
-16 brain and nervous system illness markets analyzed including: addiction, Alzheimer's disease, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, mild cognitive impairment, migraine, multiple sclerosis, obesity, pain, Parkinson's disease, retinal disorders, schizophrenia and stroke
-Analysis of biological basis, current treatment options, and emerging therapeutic strategies
-Analysis of compounds and devices in clinical trials by company, mechanism of action and stage of development for each indication
-Global and US market size, worldwide revenues for 2007
-Extensive discussion of specific technological, demographic, regulatory and intellectual property trends
Customers who bought this item also bought
The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System
The Neurotechnology Industry 2009 Report
The Eighth Annual Neurotech Leaders Forum
The Market for Neurotechnology: 2008-2012
Innovations and Trends in Clinical Trials - Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
Streamlining Clinical Trials
Mastering Phase IV Clinical Trials
The Neurodiagnostics Report: Brain Imaging, Biomarkers and NeuroInformatics
Deep Brain Stimulators Clinical Trial Analysis
State of the Clinical Trials Industry, 2009
Clinical Trials in India
Industry Insight Clinical Trials in India
|
|
|
|
